Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biosynex financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€3
2024-10-29
Market Capitalization
€33.1 M
2024-10-29
Revenue
€101.2 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 31.2M | 35.2M | 153.9M | 382.5M | 196.6M | 93.0M | 101.2M |
| Cost of goods sold | 22.5M | 15.7M | 84.6M | 176.1M | 94.3M | 43.8M | 43.7M |
| Gross profit | 8.9M | 20.4M | 84.1M | 206.4M | 112.3M | 65.4M | 80.2M |
| Gross profit margin, % | 28.5% | 58.0% | 54.6% | 54.0% | 57.1% | 70.4% | 79.3% |
| Operating expense total | 8.3M | 17.7M | 31.7M | 59.1M | 62.9M | 76.9M | 80.3M |
| Depreciation and amortization | 467.0K | 1.1M | 624.0K | 2.9M | 10.5M | 10.3M | 21.5M |
| EBITDA | 1.2M | 2.7M | 52.4M | 147.3M | 49.3M | (11.5M) | (19.0K) |
| EBITDA margin, % | 3.8% | 7.6% | 34.0% | 38.5% | 25.1% | -12.4% | 0.0% |
| EBIT | 517.0K | 1.4M | 44.7M | 139.6M | 32.9M | (19.5M) | (23.6M) |
| EBIT margin, % | 1.7% | 4.0% | 29.0% | 36.5% | 16.8% | -21.0% | -23.3% |
| Interest income | 90.0K | ||||||
| Interest expense | 236.0K | 317.0K | 487.0K | 499.0K | 4.6M | 7.7M | 8.4M |
| Pre tax profit | 371.0K | 1.3M | 44.4M | 139.6M | 29.8M | (38.2M) | (44.7M) |
| Income tax expense | (171.0K) | 154.0K | 12.2M | 32.9M | 8.6M | (2.6M) | (1.4M) |
| Net Income | 542.0K | 1.1M | 32.2M | 106.7M | 21.2M | (35.6M) | (43.3M) |